Aveanna Healthcare (NASDAQ:AVAH) Hits New 12-Month High at $5.95

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as $5.95 and last traded at $5.44, with a volume of 48044 shares. The stock had previously closed at $5.52.

Analysts Set New Price Targets

Several analysts have recently commented on AVAH shares. Royal Bank of Canada increased their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a report on Friday, August 9th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Finally, UBS Group boosted their target price on Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research note on Friday, August 9th.

Aveanna Healthcare Price Performance

The firm has a market cap of $1.06 billion, a PE ratio of -9.20 and a beta of 2.13. The business’s fifty day moving average is $4.77 and its 200-day moving average is $3.30.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million for the quarter, compared to analysts’ expectations of $494.02 million. Analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors have recently added to or reduced their stakes in the business. Mackenzie Financial Corp boosted its stake in Aveanna Healthcare by 35.9% in the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock worth $126,000 after purchasing an additional 12,075 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after buying an additional 96,600 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of Aveanna Healthcare by 176.6% in the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock valued at $222,000 after acquiring an additional 51,890 shares during the period. Bank of New York Mellon Corp grew its stake in Aveanna Healthcare by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after acquiring an additional 9,243 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.